| Catalog Number |
10995561 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/23/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The customer reported falsely elevated results on the atellica im enhanced estradiol (ee2) assay with reagent lot 096 compared to repeat testing.The initial results were reported to the physician(s) who did not question the results.There are no known reports of patient intervention or adverse health consequences due to the elevated ee2 results.
|
| |
|
Additional Manufacturer Narrative
|
|
A customer from outside the united states observed elevated atellica im enhanced estradiol (ee2) results that were considered discordant compared to repeat results.Quality control was within the 2sd range but was biased high.Maintenance was up to date and no errors were found in the event log of atellica im ih00794.The atellica im ee2 primary pack used to report the discordant results was loaded on the system on august 21, 2023.A pack calibration was performed on this pack and afterwards controls were acceptable.The interpretation of results section of the atellica im enhanced estradiol instructions for use states: "results of this assay should always be interpreted in conjunction with the patient¿s medical history, clinical presentation, and other findings." siemens continues to investigate.
|
| |
|
Additional Manufacturer Narrative
|
|
Siemens filed mdr 1219913-2023-00246 initial report on 28-sep-2023.Additional information - 25-sep-2023 section e1 was updated with the customer contact name and phone number ((b)(6)) siemens completed the investigation for an outside of the united states (ous) customer observation of atellica im enhanced estradiol (ee2), lot 096, results that were considered discordant (falsely elevated) compared to retest results.The customer had observed quality control that within the 2sd range but was biased high, therefore, a lookback and retest of patient samples was performed.Several low concentration samples recovered lower upon repeat.The lower repeat results were considered correct.The atellica im analyzer maintenance was up to date and no errors were found in event log.The atellica im ee2 primary pack used to report the discordant results was loaded on (b)(6) 2023 and was not used until after the control bias was identified.A pack calibration was performed on this pack and afterwards controls were acceptable.Siemens is unable to rule out an isolated atellica im ee2 lot 096 reagent handling and/or integrity issue with this one pack of reagent.Atellica im ee2 lot 096 met all acceptance criteria at lot release.The customer continues to report controls and patient results using ee2 lot 127096 without further concern.This issue was resolved by routine troubleshooting.A product problem was not identified.
|
| |
|
Search Alerts/Recalls
|